Nuformix (NFX)

Sector:

Pharma and Biotech

0.058p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.40
  • 52 Week Low: 0.055
  • Currency: UK Pounds
  • Shares Issued: 819.31m
  • Volume: 0
  • Market Cap: £0.47m
  • RiskGrade: 322

Nuformix Overview

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. We use our expertise in discovering, developing and patenting novel drug forms with improved physical properties, to develop new products in new indications that are differentiated from the original by way of: dosage, delivery route or presentation, thus creating new and attractive commercial opportunities.

1 Day Chart (01-11-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.1  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Nuformix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 0.61 (1.84) (0.36)p n/a n/a n/a n/a 0.0%
31-Mar-20 0.54 (0.93) (0.16)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.20 (1.38) (0.22)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.05 (1.27) (0.19)p n/a n/a n/a n/a 0.0%
30-Sep-23 n/a (0.93) (0.08)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Nuformix Company Announcements

Publication of Prospectus & Notice of GM 16-Oct-2024 13:37 RNS
£300,000 Fundraise 20-Sep-2024 14:24 RNS
Half-year Report 18-Jun-2024 07:00 RNS

Nuformix ShareCast News

Nuformix loss widens as revenue drops 15-Jul-2021 ShareCast
Nuformix seeks chairman as Blackwell quits after... 10-Feb-2021 ShareCast
Nuformix narrows losses as it progresses clinica... 18-Jul-2019 ShareCast

Latest Nuformix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.058p
Change Today 0.005p
% Change -8.00 %
52 Week High 0.40
52 Week Low 0.055
Volume 0
Shares Issued 819.31m
Market Cap £0.47m
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.68% above the market average61.68% above the market average61.68% above the market average61.68% above the market average61.68% above the market average
96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average
Price Trend
93.75% below the market average93.75% below the market average93.75% below the market average93.75% below the market average93.75% below the market average
91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average91.84% below the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page